Cardiac and Skeletal Muscle Injury in Drug Development: Advances in Biomarkers, Assessment, and Clinical Translation


Price: $0.00

The DACC 2013 Spring Meeting will explore scientific issues related to skeletal and cardiac injury. This includes mechanisms of acute and chronic skeletal and cardiac injury, preclinical predictive assays, and models currently in use or being evaluated to reduce clinical skeletal and cardiac inury in late-stage clinical trials. The symposium will consider use of routine and exploratory skeletal and cardiac biomarkers and evaluate consortium activities to develop new skeletal and cardiac biomarkers.